Compare Advanced Osteotomy Tools vs ReGelTec
Customers evaluate the quality of Advanced Osteotomy Tools's products using the following success metrics.
Overview
Advanced Osteotomy Tools is 14 yrs old and is based in Switzerland.
Advanced Osteotomy Tools is reinventing bone surgery. It develops novel digital solutions. It offers laser osteotome for clinical use and uses cold ablation laser combined with robotics, navigation, and smart software. The company was founded in 2010 and is based in Basel, Switzerland.
ReGelTec is 6 yrs old and is based in United States.
ReGelTec is a medical device company. The company develops a medical device designed for treating lower back pain and degenerative disc disease. ReGelTec was founded in 2018 and is based in Baltimore, Maryland.
Demo Video
Leadership
Alfredo E Bruno (Founder)
Anthony Lowman (Founder, Chief Technology Officer)
Investors
Zurcher Kantonalbank, SHS Capital
BCWH, Abell Foundation
Product
Why Advanced Osteotomy Tools beats ReGelTec
Information not available because ReGelTec has not claimed their profile.
Work for ReGelTec? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for ReGelTec?
Claim your profile now.
Benefits
- Increased margins on existing DRGs
- Novelty/ Possibility for publication/ new operative techniques/ new surgical field/ staff and patient marketing
Products
Customers
Advanced Osteotomy Tools works with 1 known companies.
Known Partners
Paracelsus
Why They Buy
Expert Collections
Robotics
1,974 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Digital Health
10,553 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.